Employees: 03 (2023.0)Legal category: 5485Size: PMECreation date: 2011-09-23 (14 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: VERDUN (55100), Meuse
Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.
PHARMACIE DES EPARGES : revenue, balance sheet and financial ratios
PHARMACIE DES EPARGES is a French company
founded 14 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in VERDUN (55100),
this company of category PME
shows in 2025 a net income positive of 202 k€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - PHARMACIE DES EPARGES (SIREN 534830690)
Indicator
2025
2024
2023
2022
2021
2020
2018
2017
2016
Revenue
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Net income
201 868 €
189 732 €
261 496 €
205 808 €
125 992 €
139 681 €
207 154 €
151 365 €
148 775 €
EBITDA
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Net margin
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Revenue and income statement
In 2025, PHARMACIE DES EPARGES generates positive net income of 202 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2016-2025: 149 k€ -> 202 k€.
Net income (2025)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
201 868 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 57%. Debt remains under control: the company retains capacity to raise new debt if needed. Financial autonomy (= Equity / Total assets x 100) reaches 57%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
Debt ratio (2025)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
57.334%
Financial autonomy (2025)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
57.446%
Asset age ratio (2025)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Solvency indicators evolution PHARMACIE DES EPARGES
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2017
2018
2020
2021
2022
2023
2024
2025
Debt ratio
267.227
915.124
675.917
294.958
213.063
157.867
106.324
75.626
57.334
Financial autonomy
24.061
8.598
11.573
22.63
29.175
35.274
43.673
51.96
57.446
Repayment capacity
None
None
None
None
None
None
None
None
None
Cash flow / Revenue
None%
None%
None%
None%
None%
None%
None%
None%
None%
Sector positioning
Debt ratio
57.332025
2023
2024
2025
Q1: 13.57
Med: 49.47
Q3: 128.28
Average-7 pts over 3 years
In 2025, the debt ratio of PHARMACIE DES EPARGES (57.33) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
Financial autonomy
57.45%2025
2023
2024
2025
Q1: 33.69%
Med: 53.88%
Q3: 72.26%
Good+11 pts over 3 years
In 2025, the financial autonomy of PHARMACIE DES EPARGES (57.5%) ranks above the median of the sector. This ratio represents the share of equity in total financing. This comfortable position offers an appreciable safety margin.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 275.21. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2025)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
275.213
Liquidity indicators evolution PHARMACIE DES EPARGES
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2016
2017
2018
2020
2021
2022
2023
2024
2025
Liquidity ratio
175.812
185.022
172.904
207.749
189.793
248.614
256.603
279.846
275.213
Interest coverage
None
None
None
None
None
None
None
None
None
Sector positioning
Liquidity ratio
275.212025
2023
2024
2025
Q1: 131.48
Med: 182.6
Q3: 258.72
Excellent
In 2025, the liquidity ratio of PHARMACIE DES EPARGES (275.21) ranks in the top 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio above 1 ensures comfortable coverage of short-term maturities.
Positioning of PHARMACIE DES EPARGES in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 277 transactions of similar company sales
in 2025,
the value of PHARMACIE DES EPARGES is estimated at
3 206 697 €
(range 2 176 079€ - 5 031 749€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2025
277 transactions
2176k€3206k€5031k€
3 206 697 €Range: 2 176 079€ - 5 031 749€
NAF 5 année 2025
Valuation method used
Net Income Multiple
201 868 €
×
15.9x
=3 206 697 €
Range: 2 176 080€ - 5 031 749€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 277 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare PHARMACIE DES EPARGES with other companies in the same sector:
Frequently asked questions about PHARMACIE DES EPARGES
What is the revenue of PHARMACIE DES EPARGES ?
The revenue of PHARMACIE DES EPARGES is not publicly disclosed (confidential accounts filed with INPI).
Is PHARMACIE DES EPARGES profitable?
Yes, PHARMACIE DES EPARGES generated a net profit of 202 k€ in 2025.
Where is the headquarters of PHARMACIE DES EPARGES ?
The headquarters of PHARMACIE DES EPARGES is located in VERDUN (55100), in the department Meuse.
Where to find the tax return of PHARMACIE DES EPARGES ?
The tax return of PHARMACIE DES EPARGES is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does PHARMACIE DES EPARGES operate?
PHARMACIE DES EPARGES operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart